QURE earnings date and last-quarter result: last quarter beat, P/E -11.50. Updated 2026-07-23.
uniQure (QURE) Research Hub
uniQure (QURE) trades on NASDAQ, NL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 21.65 USD (-3.48%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -11.50, market cap 2.71B. This hub links to the full technical, earnings and options research available for QURE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, NL |
| Last close | 21.65 USD (-3.48%) |
| 52-week range | 20.33 USD – 51.72 USD |
| Trend regime | Range |
| 14-day RSI | 40.6 (Bearish) |
| Trailing P/E | -11.50 |
| Market cap | 2.71B |
| Dividend yield | 0.00% |
Available research for QURE
Covered Call on QURE: how it works, illustrative setup around the real 21.65 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on QURE: how it works, illustrative setup around the real 21.65 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on QURE: how it works, illustrative setup around the real 21.65 USD price, max profit/loss, breakeven and when to use it. Educational.
QURE technical analysis: range, last 21.65 USD, RSI 40.6, 52w range 20.33 USD–51.72 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is QURE in?
uniQure (QURE) is classified under Healthcare (Biotechnology), listed on NASDAQ, NL.
Is QURE in an uptrend or downtrend?
As of 2026-10-26, QURE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is QURE's trailing P/E ratio?
QURE's trailing P/E is -11.50, with a market cap of 2.71B. See the earnings research page for full valuation detail.